M. Guerret

484 total citations
26 papers, 374 citations indexed

About

M. Guerret is a scholar working on Spectroscopy, Pharmacology and Molecular Biology. According to data from OpenAlex, M. Guerret has authored 26 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Spectroscopy, 5 papers in Pharmacology and 4 papers in Molecular Biology. Recurrent topics in M. Guerret's work include Analytical Chemistry and Chromatography (8 papers), Analytical Methods in Pharmaceuticals (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). M. Guerret is often cited by papers focused on Analytical Chemistry and Chromatography (8 papers), Analytical Methods in Pharmaceuticals (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). M. Guerret collaborates with scholars based in France, Switzerland and Japan. M. Guerret's co-authors include J.R. Kiechel, Claude Dubray, Martine Hubert, Norbert Bromet, F Forette, M Bellet, Maguy Bromet-Petit, Henri Merdjan, E. Mueller and Henry Lau and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Journal of Chromatography A and Pharmaceutical Research.

In The Last Decade

M. Guerret

25 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Guerret France	13	65	60	60	58	56	26	374
Debra M. Imhoff Australia	11	45 0.7×	67 1.1×	100 1.7×	117 2.0×	42 0.8×	13	372
Klaus D. Raemsch Germany	6	37 0.6×	90 1.5×	71 1.2×	54 0.9×	61 1.1×	8	376
Pekka Ottoila Finland	12	62 1.0×	154 2.6×	39 0.7×	64 1.1×	82 1.5×	19	506
M. G. Bogaert Belgium	16	56 0.9×	91 1.5×	79 1.3×	153 2.6×	88 1.6×	34	533
T Douglas Cowart United States	7	49 0.8×	108 1.8×	35 0.6×	50 0.9×	42 0.8×	10	347
Margareta Hammarlund Sweden	8	41 0.6×	57 0.9×	51 0.8×	55 0.9×	82 1.5×	9	381
Bernhard Scheidel Germany	9	44 0.7×	48 0.8×	48 0.8×	80 1.4×	70 1.3×	17	399
H Jaeger Germany	13	126 1.9×	39 0.7×	126 2.1×	102 1.8×	77 1.4×	58	487
CP Quarterman United Kingdom	10	42 0.6×	79 1.3×	123 2.0×	72 1.2×	24 0.4×	13	326
Janis J. MacKichan United States	12	50 0.8×	41 0.7×	72 1.2×	107 1.8×	79 1.4×	30	435

Countries citing papers authored by M. Guerret

Since Specialization

Citations

This map shows the geographic impact of M. Guerret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Guerret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Guerret more than expected).

Fields of papers citing papers by M. Guerret

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Guerret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Guerret. The network helps show where M. Guerret may publish in the future.

Co-authorship network of co-authors of M. Guerret

This figure shows the co-authorship network connecting the top 25 collaborators of M. Guerret. A scholar is included among the top collaborators of M. Guerret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Guerret. M. Guerret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guerret, M., et al.. (1999). Routine determination of morphine, morphine 3-β-d-glucuronide and morphine 6-β-d-glucuronide in human serum by liquid chromatography coupled to electrospray mass spectrometry. Journal of Chromatography A. 854(1-2). 93–108. 34 indexed citations

Zhou, Honghui, Henry Lau, M. Guerret, et al.. (1999). Effect of Meal Timing Not Critical for the Pharmacokinetics of Tegaserod (HTF 919). The Journal of Clinical Pharmacology. 39(9). 911–919. 27 indexed citations

Appel‐Dingemanse, Silke, M. Guerret, Yulia Hirschberg, & James F. McLeod. (1999). Single- and multiple-dose pharmacokinetics of SDZ HTF 919 in healthy subjects. Clinical Pharmacology & Therapeutics. 65(2). 128–128. 1 indexed citations

McLeod, James F., et al.. (1999). Pharmacokinetics (PK) of SDZ HTF 919 (HTF) not altered in subjects with severe renal insufficiency requiring hemodialysis. Clinical Pharmacology & Therapeutics. 65(2). 203–203. 10 indexed citations

Tarral, Antoine, et al.. (1997). Effects of Terbinafine on the Pharmacokinetics of Digoxin in Healthy Volunteers. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 17(4). 791–795. 7 indexed citations

Kovarik, John M., et al.. (1997). Cyclosporine and Nonsteroidal Antiinflammatory Drugs: Exploring Potential Drug Interactions and Their Implications for the Treatment of Rheumatoid Arthritis. The Journal of Clinical Pharmacology. 37(4). 336–343. 18 indexed citations

Merdjan, Henri, et al.. (1993). A mathematical model for dynamics of cardiovascular drug action: Application to intravenous dihydropyridines in healthy volunteers. Journal of Pharmacokinetics and Biopharmaceutics. 21(5). 489–514. 31 indexed citations

Atkinson, Jeffrey, et al.. (1991). The preparation and acute antihypertensive effects of a nanocapsular form of darodipine, a dihydropyridine calcium entry blocker.. Pharmaceutical Research. 8(6). 734–738. 24 indexed citations

Rocha, Paulo, et al.. (1990). Kinetics and hemodynamic effects of intravenous nicardipine modified by previous propranolol oral treatment. Cardiovascular Drugs and Therapy. 4(6). 1525–1532. 4 indexed citations

10.

Guerret, M., et al.. (1989). Simultaneous study of the pharmacokinetics of intravenous and oral nicardipine using a stable isotope. European Journal of Clinical Pharmacology. 37(4). 381–385. 12 indexed citations

11.

Delchier, J.C., et al.. (1988). Influence of digestive secretions and food on intestinal absorption of nicardipine. European Journal of Clinical Pharmacology. 34(2). 165–171. 12 indexed citations

12.

Chelly, Jacques E., Einar S. Hysing, D. R. Abernethy, et al.. (1987). Role of isoflurane on hemodynamic properties and disposition of nicardipine.. Journal of Pharmacology and Experimental Therapeutics. 241(3). 899–906. 10 indexed citations

13.

Forette, F, et al.. (1985). Effect of nicardipine in elderly hypertensive patients.. British Journal of Clinical Pharmacology. 20(S1). 125S–129S. 46 indexed citations

14.

Guerret, M., et al.. (1983). Quantification of ketotifen and its metabolites in human plasma by gas chromatography mass spectrometry. Journal of Mass Spectrometry. 10(3). 136–142. 21 indexed citations

15.

Cherruault, Y. & M. Guerret. (1983). Parameters identification and optimal control in pharmacokinetics. Acta Applicandae Mathematicae. 1(2). 105–120. 3 indexed citations

16.

Guerret, M., et al.. (1982). Determination of 3-hydroxy-guanfacine in biological fluids by electron-capture gas—liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 233(1). 181–192. 8 indexed citations

17.

Guerret, M.. (1980). Determination of pindolol in biological fluids by an electron-capture gas—liquid chromatographic method on a wall-coated open tubular column. Journal of Chromatography B Biomedical Sciences and Applications. 221(2). 387–392. 16 indexed citations

18.

Guerret, M., et al.. (1980). Determination of pindolol in biological fluids by electron-capture GLC. Journal of Pharmaceutical Sciences. 69(10). 1191–1193. 13 indexed citations

19.

Guerret, M., et al.. (1976). The effect of food and clopamide on the absorption of pindolol in man.. PubMed. 13(3). 228–32. 8 indexed citations

20.

Guerret, M., et al.. (1975). [Simultaneous determination by gas chromatography of butalbital,caffeine, amidopyrine and 2 metabolites of the latter in plasma and urine].. PubMed. 32(9-10). 505–12. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact